ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
This report contains market size and forecasts of Enzyme-Linked Immunosorbent Assay (ELISA) in Global, including the following market information:
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at 184.2 million in 2021 and is projected to reach US$ 233.5 million by 2028, at a CAGR of 3.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sandwich ELISA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA) include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioMérieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzyme-Linked Immunosorbent Assay (ELISA) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, by Type, 2021 (%)
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, by Application, 2021 (%)
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzyme-Linked Immunosorbent Assay (ELISA) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Enzyme-Linked Immunosorbent Assay (ELISA) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering